Previous close | 1.5100 |
Open | 1.6500 |
Bid | 1.4200 x 800 |
Ask | 1.4300 x 1100 |
Day's range | 1.4200 - 1.6600 |
52-week range | 1.0400 - 3.2300 |
Volume | |
Avg. volume | 360,245 |
Market cap | 76.65M |
Beta (5Y monthly) | 1.23 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.6900 |
Earnings date | 10 May 2024 - 14 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 28 Aug 1996 |
1y target est | 8.47 |
VIENNA, Va., May 08, 2024--CEL-SCI receives FDA go-ahead for its confirmatory study of Multikine in the treatment of head & neck cancer.
VIENNA, Va., April 23, 2024--CEL-SCI appoints Mario Gobbo to its Board of Directors.
VIENNA, Va., March 19, 2024--CEL-SCI’s LEAPS vaccine offers promising new paradigm to treat rheumatoid arthritis: published in Frontiers in Immunology.